BFC Planning’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
BFC Planning's COGT Position: Q3 2026 in Review
BFC Planning increased its Cogent Biosciences (COGT) stake by 23% in Q3 2026, buying an estimated $776 and bringing the position to 113 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2814.
BFC Planning first reported a position in COGT in Q1 2026 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.
- BFC Planning held 113 shares of Cogent Biosciences worth $3.62K as of Q3 2026.
- BFC Planning bought 21 Cogent Biosciences shares in Q3 2026, an estimated $776.
- Cogent Biosciences made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2814 holding.
- BFC Planning first reported a position in Cogent Biosciences in Q1 2026 and has held it in 3 quarters since.
- 202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.